Skip to main content
. 2021 Jun 12;12(6):609. doi: 10.1038/s41419-021-03895-2

Fig. 7. LincZNF337-AS1 promotes acetylation of H2A.Z through KAT5.

Fig. 7

ab RNA-pulldown assay verifies lincZNF337-AS1 binding to KAT5, not KAT3. c RIP-qPCR assay verifies lincZNF337-AS1 binding to KAT5, not KAT3. d Co-IP assay identifies the interaction between H2A.Z and KAT5 in HCC cell lines. e Identification of KAT5 gene knockdown effect by western blot. f, i The effect of knockdown KAT5 and lincZNF337-AS1 on H2A.Z acetylation detected by Co-IP assay. h RNA-pulldown assay verifies the binding site of lincZNF337-AS1 to KAT5 in HepG2 and MHCC-97H cell lines. The data are expressed in terms of mean ± SD (Student’s t-test used in Fig c and g; ****P < 0.0001; n = 3 in each group).